NASDAQ:RVMD

Revolution Medicines Stock News

Healthcare > Biotechnology

Buy RVMD

*Your capital is at risk

$169.51

+3.70 (+2.23%)

At Close: Jun 23, 2026

Revolution Medicines Announces Proposed Public Offering of Common Stock

04:01pm, Monday, 01'st Feb 2021

REDWOOD CITY, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD) today announced that it has commenced an underwritten public offering of 4,000,000 shares of common st

Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference

07:30am, Tuesday, 05'th Jan 2021

REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company developing targeted therapies to inhibit frontier targets

Why Revolution Medicines Stock Is Trading Higher

03:45pm, Thursday, 12'th Nov 2020

Revolution Medicines (NASDAQ: RVMD) shares are trading higher on Thursday after the company reported a third-quarter EPS loss of 42 cents, up from a loss of $6.08 year-over-year and sales $12.66 milli

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by